Breaking News Instant updates and real-time market news.

AERI

Aerie Pharmaceuticals

$55.35

2.65 (5.03%)

09:38
10/11/17
10/11
09:38
10/11/17
09:38

Aerie jumps after FDA posts briefing documents ahead of Rhopressa meeting

The FDA has called a meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee, to be held October 13, to discuss Aerie Pharmaceuticals' Rhopressa for the proposed indication of reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. As is its standard practice, the FDA has made background material available to the public two business days before the meeting. Following the posting of the briefing documents to the FDA website, Aerie shares are up 14% to $63.20 in early trading.

  • 13

    Oct

  • 28

    Feb

AERI Aerie Pharmaceuticals
$55.35

2.65 (5.03%)

09/07/17
MZHO
09/07/17
INITIATION
Target $70
MZHO
Buy
Aerie Pharmaceuticals initiated with a Buy on glaucoma opportunity at Mizuho
As previously reported, Mizuho initiated Aeri Pharmaceuticals with a Buy and a $70 price target. Analyst Difei.Yang said Aeri is well positioned for FDA approvals of its two glaucoma drugs, Rhopressa and Roclatan in 2018-2019. If both are approved, he said the drugs would bring options for treating glaucoma with the first new mechanism of actions in nearly 20 years and sees potential for a buyout ahead of the FDA approvals in 2018
09/22/17
JMPS
09/22/17
NO CHANGE
Target $68
JMPS
Outperform
Aerie pullback on AdComm announcement a buying opportunity, says JMP Securities
JMP Securities analyst Donald Ellis said Aerie management has broadcast their expectations for an advisory committee for Rhopressa "since day one" and he is still highly confident the vote will support a recommendation for approval. He views the pullback of the stock on the announcement of the meeting as a buying opportunity and reiterates his Outperform rating and $68 target on Aerie shares.
10/02/17
MZHO
10/02/17
NO CHANGE
Target $70
MZHO
Buy
Aerie recent weakness a buying opportunity, says Mizuho
Mizuho analyst Difei Yang noted that Aerie Pharmaceuticals shares have fallen by about 20% since the company announced on September 20 that the FDA will hold an advisory committee meeting to discuss Rhopressa. However, after speaking with Aerie's management, the analyst believes a fair amount of preparation had already taken place prior to receiving the FDA notice and views the pullback in the stock as a buying opportunity. Yang keeps a $70 price target and Buy rating on Aerie shares.
10/05/17
COWN
10/05/17
NO CHANGE
Target $100
COWN
Outperform
Aerie Pharmaceuticals should receive positive FDA review next week, says Cowen
Cowen analyst Tyler Van Buren conducted an ophthalmology panel and survey and received very optimistic responses suggesting Rhopressa should receive a positive advisory committee vote on October 13, which should ultimately lead to approval. The panelists he spoke to believed the company's Rocket clinical trial program demonstrated that Rhopressa is an effective agent as it achieved non-inferiority to timolol, said Van Buren, who reiterated his Outperform rating and $100 price target on Aerie Pharmaceuticals shares.

TODAY'S FREE FLY STORIES

TYL

Tyler Technologies

$179.58

0.07 (0.04%)

05:21
10/17/17
10/17
05:21
10/17/17
05:21
Downgrade
Tyler Technologies rating change  »

Tyler Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

ICUI

ICU Medical

$188.40

0.9 (0.48%)

05:20
10/17/17
10/17
05:20
10/17/17
05:20
Initiation
ICU Medical initiated  »

ICU Medical initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

NFLX

Netflix

$202.68

3.19 (1.60%)

05:17
10/17/17
10/17
05:17
10/17/17
05:17
Recommendations
Netflix analyst commentary  »

Netflix price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

EQT

EQT Corporation

$62.56

-0.45 (-0.71%)

, RICE

Rice Energy

$27.32

-0.2 (-0.73%)

05:17
10/17/17
10/17
05:17
10/17/17
05:17
Hot Stocks
EQT Corporation reiterates benefits of pending acquisition of Rice Energy »

EQT Corporation (EQT),…

EQT

EQT Corporation

$62.56

-0.45 (-0.71%)

RICE

Rice Energy

$27.32

-0.2 (-0.73%)

EQGP

EQT GP

$29.71

-0.53 (-1.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

  • 14

    Nov

  • 15

    May

  • 16

    May

NFLX

Netflix

$202.68

3.19 (1.60%)

05:12
10/17/17
10/17
05:12
10/17/17
05:12
Recommendations
Netflix analyst commentary  »

Netflix price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

CMC

Commercial Metals

$20.50

-0.28 (-1.35%)

, GGB

Gerdau

$3.57

-0.01 (-0.28%)

05:11
10/17/17
10/17
05:11
10/17/17
05:11
Upgrade
Commercial Metals, Gerdau rating change  »

Commercial Metals…

CMC

Commercial Metals

$20.50

-0.28 (-1.35%)

GGB

Gerdau

$3.57

-0.01 (-0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

SECO

Seeco Holding

$8.30

0.14 (1.72%)

05:07
10/17/17
10/17
05:07
10/17/17
05:07
Initiation
Seeco Holding initiated  »

Seeco Holding initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGN

Allergan

$198.41

-7.11 (-3.46%)

05:06
10/17/17
10/17
05:06
10/17/17
05:06
Recommendations
Allergan analyst commentary  »

Allergan price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 23

    Oct

  • 01

    Nov

  • 06

    Nov

EV

Eaton Vance

$51.10

0.03 (0.06%)

05:02
10/17/17
10/17
05:02
10/17/17
05:02
Initiation
Eaton Vance initiated  »

Eaton Vance initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FII

Federated Investors

$31.48

0.2 (0.64%)

05:02
10/17/17
10/17
05:02
10/17/17
05:02
Initiation
Federated Investors initiated  »

Federated Investors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

JHG

Janus Henderson Group

$35.22

-0.08 (-0.23%)

05:01
10/17/17
10/17
05:01
10/17/17
05:01
Initiation
Janus Henderson Group initiated  »

Janus Henderson Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LM

Legg Mason

$37.63

-1.11 (-2.87%)

05:01
10/17/17
10/17
05:01
10/17/17
05:01
Initiation
Legg Mason initiated  »

Legg Mason initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

WETF

WisdomTree

$11.00

0.01 (0.09%)

05:00
10/17/17
10/17
05:00
10/17/17
05:00
Initiation
WisdomTree initiated  »

WisdomTree initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCX

Freeport McMoRan

$15.27

0.52 (3.53%)

04:59
10/17/17
10/17
04:59
10/17/17
04:59
Downgrade
Freeport McMoRan rating change  »

Freeport McMoRan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

ERJ

Embraer

$21.42

-0.63 (-2.86%)

, EADSY

Airbus

$22.75

-0.07 (-0.31%)

04:56
10/17/17
10/17
04:56
10/17/17
04:56
Downgrade
Embraer, Airbus rating change  »

Embraer downgraded to…

ERJ

Embraer

$21.42

-0.63 (-2.86%)

EADSY

Airbus

$22.75

-0.07 (-0.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADP

ADP

$114.58

0.72 (0.63%)

, CSOD

Cornerstone OnDemand

$39.02

0.02 (0.05%)

04:55
10/17/17
10/17
04:55
10/17/17
04:55
Conference/Events
Stephens human capital management team holds analyst/industry conference call »

Enterprise Software…

ADP

ADP

$114.58

0.72 (0.63%)

CSOD

Cornerstone OnDemand

$39.02

0.02 (0.05%)

MSFT

Microsoft

$77.65

0.16 (0.21%)

ORCL

Oracle

$48.86

0.25 (0.51%)

PAYC

Paycom

$78.99

-0.9 (-1.13%)

PCTY

Paylocity

$50.08

0.17 (0.34%)

SAP

SAP

$111.84

-0.88 (-0.78%)

ULTI

Ultimate Software

$194.45

-3.47 (-1.75%)

WDAY

Workday

$107.23

-2.13 (-1.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 22

    Oct

  • 26

    Oct

  • 31

    Oct

  • 01

    Nov

  • 02

    Nov

  • 02

    Nov

  • 05

    Nov

  • 08

    Nov

  • 15

    Nov

WES

Western Gas Partners

$50.92

-0.38 (-0.74%)

04:55
10/17/17
10/17
04:55
10/17/17
04:55
Conference/Events
Western Gas Partners to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

04:55
10/17/17
10/17
04:55
10/17/17
04:55
Conference/Events
Stephens food & agribusiness analyst holds an analyst/industry conference call »

Food & Agribusiness…

SFNC

Simmons First National

$58.90

0.45 (0.77%)

, OKSB

Southwest Bancorp

$28.05

0.15 (0.54%)

04:55
10/17/17
10/17
04:55
10/17/17
04:55
Conference/Events
Southwest Bancorp to host special shareholder meeting »

Special Shareholder…

SFNC

Simmons First National

$58.90

0.45 (0.77%)

OKSB

Southwest Bancorp

$28.05

0.15 (0.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 18

    Oct

  • 23

    Oct

CLSD

Clearside Biomedical

$7.77

0.03 (0.39%)

04:55
10/17/17
10/17
04:55
10/17/17
04:55
Conference/Events
Clearside Biomedical management to meet with JMP Securities »

Meetings to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

AKR

Acadia Realty Trust

$30.26

-0.2 (-0.66%)

04:55
10/17/17
10/17
04:55
10/17/17
04:55
Conference/Events
Acadia Realty Trust management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 03

    Nov

04:55
10/17/17
10/17
04:55
10/17/17
04:55
Conference/Events
Citigroup to hold a conference »

9th Annual Australian…

GSM

Ferroglobe

$14.56

0.39 (2.75%)

04:55
10/17/17
10/17
04:55
10/17/17
04:55
Conference/Events
Ferroglobe to hold investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 14

    Nov

  • 15

    Nov

04:55
10/17/17
10/17
04:55
10/17/17
04:55
Conference/Events
Senate Banking, Housing & Urban Affairs Committee to hold a hearing »

The Committee holds a…

04:55
10/17/17
10/17
04:55
10/17/17
04:55
Conference/Events
Senate Health, Ed, Labor & Pensions Committee holds a hearing »

The Committee holds a…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.